Radiation Medicine

Ronald Charles McGarry, MD, PhD
Vice-Chair for Research, Professor,
and Director of Body Radiosurgery Program
Department of Radiation Medicine
Chandler Medical Center, Pavilion H
800 Rose Street C-114C
Lexington, KY 40536-0293
Phone: (859) 323-6486
Fax: (859) 257-7483
Email: ronald.mcgarry@uky.edu

RESEARCH INTERESTS:

• Lung Cancer
• Stereotatic body radiation therapy
• Lymphoma
• Clinical trials

EDUCATION:

• M.D., University of Calgary, 1992
• Ph.D., University of Western Ontario, 1981
• M.Sc., University of Western Ontario, 1977
• B.Sc., University of Western Ontario, 1975

BOARD CERTIFICATION:

American Board of Radiology, Radiation Oncology, 1999

SELECTED PUBLICATIONS:

McGarry, R.C. Extracranial stereotactic body radiotherapy in the management of early stage non-small cell lung cancer: a case study. In: Stereotactic Body Radiation Therapy    (Kavanaugh, B. and Timmerman, R.,eds. ) Lippincott, Williams and Wilkins, pp. 110-113. 2005

Turrisi, D. and McGarry, R.C. Lung Cancer. in Handbook of Radiation Oncology: Basic Principles and Clinical Protocols. (Haffty, R.G. and Wilson, L. eds). Jones and Bartlett, Boston. Chapter 18 2008.

McGarry, R. C.  2007.  Stereotactic Body Radiation Therapy in the Treatment of Early Stage Lung Cancer. In Treating Tumors that Move with Respiration. (Urschel, H.C. ed) Robotic Radiosurgery, Springer-Verlag. pp117-124.

McGarry, R. C.  Local Control in Stage III Non-Small Cell Lung Cancer : Quo Vadis? Commentary. Am. J. Hem./Oncol. 6(9): 513-515. 2008.

Lo, S.S., Cardenes, H.R., The, B.S., Fakiris, A.J., Papiez, L., McGarry, R. C., Wang, J.Z. et al. Stereotactic Body Radiation Therapy for Nonpulmonary Primary Tumors. Exp. Review in Anticancer Ther. 8(12):1939-51. 2008.

Lo, S.L., Fakiris, A.J., Papiez, L., Abduhlrahman, R., McGarry, R.C., Henderson, M.A, Forquer, J.A., Hoopes, D., Timmerman, R.T. Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer. Expert Rev. in Anticancer Ther.. Jan; 8(1): 87-98. 2008.

McGarry, R. C. Spine Radiosurgery. Eds Gerszten, P. and Ryu, S. IJROBP Invited book review. 74(2): 653. 2009.

Tuanquin, L.C. and McGarry, R.C. Relapsed or Refractory Hodgkin’s Lymphoma: Dilemmas in Balancing the Risks and Benefits of Therapeutic Modalities Commentary. Am. J. Hem./Oncol.  8(7) 342-350. 2009.

Shah, P.H. and McGarry, R.C. Adjuvant Chemotherapy for Stage IB Non-small Cell Lung Cancer: A Conundrum. Am. J. Hem./Oncol. 8(10): 497-499. 2009.

Forquer, J.A., Fakiris, A.J.,  McGarry, R.C., Lo, S.S., Watson, C., Harkenrider, M., Henderson, M.A., and   Johnstone, P.A.S. Treatment Options for Stage I Non-Small Cell Lung Carcinoma Patients Not Suitable for Lobectomy. Expert Rev. in Anticancer Ther. 9(10):1443-53, 2009.

Lo, S.S., Fakiris, A.J., Teh, B.S.,  Cardenes, H. R., Henderson, M.A., Forquer, J.A., Papiez, L., McGarry, R.C., Wang, J.Z., Li, K., Mayer, N.A., Timmerman, R.D. Stereotactic Body Radiation Therapy for Oligometastases. 9(5): 621-35. 2009.

Lo, S.S., Fakiris, A.J., Chang, E.L., Mayer, N.A., Wang, J.Z., Papiez, L., Teh, B.S., McGarry, R.C., Cardenes, H. R., Timmerman, R.D., Stereotactic Body Radiation Therapy: A Novel Cancer Treatment Modality. Nature Reviews, Clinical Oncology, 7:44-54. 2010

PUBLISHED ARTICLES

McGarry, R.C., Papiez, L., Williams, M., Whitford, T., and Timmerman, R.T., Stereotactic Body Radiation Therapy of Early Stage Non-small Cell Lung Carcinoma: Phase I Study. Int. J. Rad. Oncol. Biol. Phys. 63(4): 1010-1015. 2005.

Sinha, B. and McGarry, R. C. Extracranial stereotactic body radiation therapy in the management of bilateral pulmonary cancer. Int. J. Rad. Oncol. Biol. Phys. 66(4):1120-1124.  2006. 

Kavanagh, B.D., McGarry, R.C. and Timmerman, R.D Extracranial Radiosurgery (aka Stereotactic Body Radiation Therapy) for Oligometastases. Sem. Rad. Oncol. 16(2):77-84, 2006.

Timmerman R.,  McGarry, R.C., Yiannoutsos, C.,  Ewing, M., Papiez, L., Tudor, K.,  DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., and  Fletcher, J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol. 24(30):4833-4839. 2006.

Xu, Y.-H., Jagtap, M.R., Zhang, D.-B., Ying, J., McGarry, R.C., Mendonca, M.S., McLennan, G.. Kinetics of iododeoxyuridine release from sodium alginate hydrogel in vitro  Journal of Interventional Radiology 15 (5), pp. 293-298. 2006.

Xu, Y., Jagtap, M.R., Garland, T., McGarry, R.C., Mendonca, M.S. and McLennan, G. Iododeoxyuridine (IudR) uptake in Proliferating Smooth Muscle Cells. J. Vasc. Intervent. Radiol.  18(1 Pt 1): 73-8. 2007

L.Berk, L.,  Berkey, B., Rich, T., Hrushesky, W., Blask, D., Gallagher, M., Kudrimoti, M., McGarry, R.C., Suh, J. and Mehta, M. A Randomized Phase II Trial of High Dose Melatonin and Radiation Therapy for RPA Class 2 Patients with Brain Metastases (RTOG 0119). Int.J. Radiat. Oncol. Biol. Phys. Jul 1; 68(3): 673-81. 2007

Hoopes, D.J., Tann, M., Fletcher, J., Forquer, J.A., Lin, P., Lo, S., Timmerman, R. and McGarry, R.C.  FDG-PET and Stereotactic Body Radiotherapy (SBRT) for Stage I Non-Small-Cell Lung Cancer. Lung Cancer 56:229-234. 2007.

Tnnel, B., McGarry, R.C., Mendonca, M.S., Cummings, O., Chin-Sinex, H., Timmerman, R.D. Pulmonary Hilar Stereotactic Body Radiation Therapy in the Rat. TCRT.  6(5): 424-432. 2007.

Hanna N., Neubauer M., McGarry R., et al. Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023.  J. Thorac. Oncol; 2:8 (abstract B5-01). (Reviewed abstract). 2008.

Hanna, N.,  Neubauer, M., Yiannoutsos, C.  McGarry, R., Arseneau, J.,  Ansari, R., Reynolds, C., Govindan, R.,  Melnyk, A., Fisher, W., Richards, D.,  Bruetman, D., Anderson, T., Chowhan, N.,  Nattam, S.,  Mantravadi, P., Johnson, C., Breen, T.,  White,A., Einhorn, L. Cisplatin plus etoposide plus concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small cell lung cancer (NSCLC): a randomized phase III study from the Hoosier Oncology Group and U.S. Oncology. JCO. 26:5755-5760. 2008. 

Henderson, M; McGarry, R; Yiannoutsos, C; Fakiris, A; Hoopes, D; Williams, M; Timmerman, R.   Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. Oct 1; 72(2): 404-409. 2008

Fakiris, A.J., McGarry, R.C., Yiannoutsos, C., Papiez, L., Williams, M.,  Henderson, M.A., Timmerman, R.  Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Carcinoma: 4 Year Results of a Prospective Phase II Study. Int.J. Radiat. Oncol. Biol. Phys.75(3):677-682. 2009.

Forquer, J.A., Fakiris, A.J., Timmerman, R.D., Lo, S.S., Perkins, S.M., McGarry, R.C., Johnstone, P.A.S. Brachial Plexopathy from Stereotactic Body Radiotherapy in Early Stage NSCLC: Dose-Limiting Toxicity in Apical Tumor Sites. Radiotherapy & Oncology. 93(3):408-13, 2009

 Henderson, M.A, Hoopes, D., Fletcher, J. , Lin, P. , Tann, M., Yiannoutsos, C.T., Williams, M., Fakiris, A.J., McGarry, R.C., Timmerman, R..    A Pilot Trial of Serial FDG-PET in Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer Treated with Hypofractionated Stereotactic Body Radiotherapy (SBRT). Int.J. Radiat. Oncol. Biol. Phys. 76(3):789-795. 2010.

J. Feddock, R. McGarry. “Safety and Toxicity of Linac-based Stereotactic Body Radiotherapy (SBRT) Boost to Residual Disease in Locally Advanced Non-small Cell Lung Cancer: Preliminary Results of a  Single Institution Feasibility Study.” Int J Rad. Oncol. Biol.Physics 78 (Suppl 1):S108, Abstract #231, 2010. (ASTRO Oral Presentation)

Barriger, R.B., Fakiris, A.J., Hanna, N., Menggang, Y., Montravadi, P. and McGarry, R.C. “Dose-Volume Analysis of Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated With Concurrent  Cisplatinum and Etoposide With or Without Consolidation Docetaxel.” Int.  J. Rad. Oncol. Biol. Physics 78(5): 1381-1386,  2010.